• 1. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 2. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 3. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 4. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

Research Briefing on 1-(4-Bromo-3-trifluoromethylphenylsulfonyl)piperidine (CAS: 1065074-37-4)

1-(4-Bromo-3-trifluoromethylphenylsulfonyl)piperidine (CAS: 1065074-37-4) is a specialized sulfonamide derivative that has garnered significant attention in recent chemical and pharmaceutical research. This compound, characterized by its bromo- and trifluoromethyl-substituted phenyl ring linked to a piperidine moiety via a sulfonyl group, exhibits unique physicochemical properties that make it a promising candidate for various applications, including drug discovery and medicinal chemistry.

Recent studies have focused on the synthesis and optimization of 1-(4-Bromo-3-trifluoromethylphenylsulfonyl)piperidine, leveraging its structural features to explore its potential as a building block for bioactive molecules. The trifluoromethyl group, in particular, is known to enhance metabolic stability and lipophilicity, which are critical factors in drug design. Researchers have employed advanced synthetic methodologies, such as palladium-catalyzed cross-coupling reactions, to functionalize this compound further and diversify its applications.

In the context of drug discovery, 1-(4-Bromo-3-trifluoromethylphenylsulfonyl)piperidine has been investigated as a key intermediate in the development of kinase inhibitors and other targeted therapies. Preliminary in vitro studies suggest that derivatives of this compound exhibit inhibitory activity against specific protein kinases, which are implicated in various cancers and inflammatory diseases. These findings underscore the compound's potential as a scaffold for designing novel therapeutic agents.

Beyond its pharmacological applications, 1-(4-Bromo-3-trifluoromethylphenylsulfonyl)piperidine has also been explored in material science. Its robust chemical structure and stability make it suitable for use in the synthesis of advanced polymers and coatings. Researchers have reported its incorporation into polymeric matrices to enhance thermal and chemical resistance, opening new avenues for industrial applications.

Despite these promising developments, challenges remain in the large-scale synthesis and purification of 1-(4-Bromo-3-trifluoromethylphenylsulfonyl)piperidine. Recent efforts have focused on optimizing reaction conditions to improve yield and reduce byproduct formation. Additionally, computational studies have been employed to predict the compound's reactivity and interactions with biological targets, providing valuable insights for future research.

In conclusion, 1-(4-Bromo-3-trifluoromethylphenylsulfonyl)piperidine (CAS: 1065074-37-4) represents a versatile and valuable compound in the fields of medicinal chemistry and material science. Ongoing research aims to further elucidate its potential applications and address existing challenges in its synthesis and utilization. As the scientific community continues to explore this compound, it is expected to play an increasingly important role in the development of next-generation therapeutics and materials.

• 951884-69-8(1-(3-Bromo-5-trifluoromethylphenylsulfonyl)piperidine)
• 332906-22-6(1-(4-Bromo-3-methylphenylsulfonyl)piperidine)
• 850429-73-1(1-(3-Bromo-4-methylphenylsulfonyl)piperidine)
• 957062-78-1(N,N-Dipropyl 3-bromo-5-trifluoromethylbenzenesulfonamide)
• 387350-79-0(Benzenesulfonamide,N-cyclopropyl-N-4-piperidinyl-3-(trifluoromethyl)-)
• 120465-85-2(3,7-Diazabicyclo[3.3.1]nonane,3-butyl-9,9-dimethyl-7-[[3-(trifluoromethyl)phenyl]sulfonyl]-, hydrochloride(1:1))
• 850429-75-3(1-(3-Bromo-4-methylphenylsulfonyl)pyrrolidine)
• 1020253-03-5(N,N-Diethyl 4-bromo-3-trifluoromethylbenzenesulfonamide)
• 939989-87-4(4-Bromo-N,N-dimethyl-3-(trifluoromethyl)benzenesulfonamide)
• 1020253-00-2(N-Propyl 4-Bromo-3-trifluoromethylbenzenesulfonamide)